Menu Close

Category: Daily News

Statute of Limitations Applies After Carriers Unequivocal Claim Denial

Sudarshan b in Fremont, California. The policy’s “Suit Against Us” provision, tracking the standard fire policy language in Insurance Code section 2071, required that any lawsuit on the policy be brought within one year of the loss, extended to two years for losses related to a declared state of emergency.

In January 2021, after a tenant vacated the property, Kumar discovered water damage and mold in the garage, apparently caused by a leaking water heater, and reported the loss to Mid-Century on February 3, 2021. On February 10, Mid-Century mailed a letter denying coverage for the mold and wear-and-tear damage, but continued investigating potential coverage for related water damage; on February 16, following a follow-up inspection, Mid-Century mailed Kumar a second letter along with a $5,010.93 payment for covered drywall damage, again stating that it had “completed the adjustment” and was “closing” the claim, and that the claim would not be reopened absent written notice.

Over the following two years, Kumar intermittently submitted additional information and a $555,700 rebuild estimate, and Mid-Century responded in writing each time — requesting supporting documentation, quoting the one-year suit provision, and in an April 2021 letter stating it would “be happy to reopen” the claim if Kumar provided the requested materials within the policy deadline. Kumar never provided that documentation, and Mid-Century’s contractor-verification efforts and a July 2021 engineering inspection both confirmed no additional coverage existed.

On January 18, 2023, one day after his last email exchange with Mid-Century, Kumar, representing himself, sued for breach of contract, breach of the covenant of good faith and fair dealing, misrepresentation, fraud, and unfair competition, seeking repair costs and loss-of-use damages.

Mid-Century moved for summary judgment on the ground that Kumar’s suit was barred by the policy’s one-year limitations period. Kumar opposed, arguing Mid-Century never issued an “unequivocal” denial sufficient to end the tolling period, and alternatively that the limitations period was equitably tolled, that Mid-Century was estopped from asserting the defense, and that the COVID-19 state of emergency extended the deadline to two years. In support, Kumar submitted a declaration stating that unidentified Mid-Century representatives told him orally in early 2021 that he had two years to sue, and that his limited English proficiency required him to rely on those oral statements over the written notices.

The Alameda County Superior Court granted summary judgment, finding Mid-Century’s February 2021 correspondence an unequivocal denial that started the one-year clock, making Kumar’s January 2023 complaint untimely, and entered judgment for Mid-Century in March 2025.

In the published case of Kumar v. Mid-Century Insurance Company, No. A173097 (Cal. Ct. App., 1st Dist., Div. 2, July 2026) — the Court of Appeal affirmed the trial court’s grant of summary judgment in favor of Mid-Century. This opinion was originally filed on June 30, 2026 and was not initially certified for publication; on July 22, 2026, the First Appellate District, Division Two, ordered it published in the Official Reports. It is now citable authority.

The summary judgment was reviewed de novo, applying the settled rule that an insurance policy’s limitations period is tolled “from the time the insured files a timely notice … to the time the insurer formally denies the claim in writing,” citing Hydro-Mill Co., Inc. v. Hayward, Tilton & Rolapp Ins. Associates, Inc. (2004) 115 Cal.App.4th 1145 and Prudential-LMI Com. Insurance v. Superior Court (1990) 51 Cal.3d 674. That formal-denial requirement means an “unequivocal” written denial, and neither an insurer’s invitation for further information nor an insured’s request for reconsideration reopens the tolling period, citing Migliore v. Mid-Century Ins. Co. (2002) 97 Cal.App.4th 592 and Singh v. Allstate Ins. Co. (1998) 63 Cal.App.4th 135.

Applying that framework, the panel held Mid-Century’s February 16, 2021 letter — which stated the adjustment was complete, the claim was closed, and it would not be reopened absent written notice, while accompanying a settlement payment — was an unequivocal denial as a matter of law, eliminating any pending claim to which tolling could still apply. The court rejected Kumar’s argument that Mid-Century’s repeated invitations for additional information created ambiguity, explaining that Migliore squarely rejected the identical argument on nearly identical facts, and that Kumar’s own subjective understanding of the correspondence was not a basis for finding a denial equivocal. Because the record showed at least five separate written statements from Mid-Century that the claim was closed, each accompanied by the “Suit Against Us” language, the court found no triable issue on this point.

The panel likewise rejected Kumar’s remaining defenses. His estoppel argument failed both because he never pleaded estoppel in his complaint, foreclosing it as a basis to oppose summary judgment, and because Mid-Century’s invitations to submit further information, made only in response to Kumar’s own requests and paired with repeated disclosure of the limitations period, could not support the intent-to-mislead element estoppel requires. Finally, the panel held Kumar’s fraud, misrepresentation, and unfair competition claims were, at their core, claims seeking policy benefits and therefore governed by the same one-year period, since “the applicable limitations period is determined by the gravamen of the complaint rather than the named cause of action,” citing Jang v. State Farm Fire & Casualty Co. (2000) 80 Cal.App.4th 1291 — and that Kumar had, in any event, forfeited any argument for treating those claims as independent torts by failing to raise it in the trial court.

Generative AI Tools Are Reshaping Insurance Fraud Risks

Two studies published in the first half of 2026 paint a consistent picture of how generative AI is reshaping insurance fraud.

The first is Verisk’s State of Insurance Fraud study, based on surveys of 1,000 U.S. consumers and 300 insurance claims professionals. Its central finding is less about criminal fraud rings and more about a widening “ethics gap” among ordinary policyholders: 36% of consumers say they would at least somewhat consider digitally altering a claim image or document to strengthen their case, even knowing it would break insurer rules, and that number climbs to 55% among Generation Z respondents and 49% among Millennials, compared with just 28% of Generation X and 12% of Baby Boomers.

Verisk also found that 41% of consumers know someone who has used AI editing tools to alter a photo, video, or document for financial gain in some context, including insurance claims.

On the industry side, 98% of insurers agree AI-powered editing tools are driving a rise in digital media fraud and 99% say they’ve personally encountered manipulated or AI-altered documentation, yet confidence in detection lags well behind that awareness: just 32% of insurers say they’re very confident they could identify a deepfake, and only 43% feel very confident assessing the authenticity of digital media at scale. Two-thirds of insurers (66%) believe digital media fraud goes undetected often or very often industry-wide.

The second is the 2026 Anti-Fraud Technology Benchmarking Report, the fourth installment of a joint research series the Association of Certified Fraud Examiners and data-analytics firm SAS have run since 2019, based on a survey of 713 fraud fighters across eight world regions (not limited to insurance, but heavily represented by financial services and insurance professionals).

Its headline finding: just 7% of anti-fraud professionals say their organizations are more than moderately prepared to detect or prevent AI-fueled fraud. The same research series found, in a preview released for International Fraud Awareness Week in November 2025, that 77% of anti-fraud professionals had already seen an acceleration in deepfake-driven social engineering over the prior 24 months, and 83% expect that trend to continue accelerating over the next two years.

The 2026 report also flags a governance gap behind the detection gap: only 18% of organizations that use AI in fraud-fighting say they test those models for bias or fairness, and just 6% feel completely confident explaining how their own AI models reach their fraud decisions.

Separately, insurance-specific vendors have demonstrated the underlying mechanics driving these concerns. SAS’s own insurance fraud specialists have published public demonstrations showing how easily generative AI tools can fabricate a convincing vehicle crash scene or add plausible property damage to an ordinary photo in seconds, using tools accessible to anyone with a computer, and reinsurer Swiss Re’s 2025 SONAR emerging-risk report similarly flagged a rising, UK-documented increase in deepfake use in low-value claims fraud specifically.

None of these sources put a specific dollar figure or percentage breakdown on how much of current insurance fraud is AI-generated as opposed to conventional — and none of the credible sources reviewed for this report claim to. That, itself, may be the most useful finding for insurance professionals: the industry’s own major research bodies are documenting a fast-growing, poorly quantified threat and a real detection gap, rather than a fraud phenomenon anyone can point to with confident overall dollar figures yet.

What this means for insurers and claims organizations:

– – Close the detection-confidence gap before it becomes a liability gap. With only 7% of fraud fighters more than moderately prepared for AI-fueled fraud and just 32% of insurers confident they could spot a deepfake, detection capability is the most exposed weak point right now. Benchmark existing fraud-detection tools specifically against synthetic-document and deepfake scenarios, not just traditional image manipulation, and treat this as distinct from general fraud-analytics investment.
– – Govern the AI tools being deployed, not only the AI tools being defended against. With only 18% of organizations testing their own anti-fraud AI models for bias and just 6% able to confidently explain their models’ decisions, insurers face growing regulatory exposure on the deployment side as well as the detection side. Oklahoma’s own Bulletin 2024-11, aligned with the NAIC’s model AI bulletin, is one example of regulators formalizing expectations of fairness, accountability, and transparency in AI-supported claims decisions; model governance should be treated as a compliance requirement, not an afterthought.
– – Address the ethics gap at the point of submission. Verisk’s finding that roughly half of Gen Z and Millennial consumers would consider altering claim evidence suggests a meaningful share of this problem is casual policyholder behavior rather than organized fraud rings. That argues for consumer-facing friction at upload — clear rule disclosures, provenance and metadata checks on submitted images — rather than relying solely on forensic detection after the fact.
– – Invest in shared intelligence, not solo detection. Because the same AI-generated assets can be recycled across carriers, cross-industry data-sharing consortia and state fraud bureaus become more valuable as the cost of generating fraudulent evidence falls; no single insurer’s claims history is enough to catch a pattern designed to be reused.
– – Weigh vendor fraud statistics with some skepticism. Several point-solution vendors selling AI-detection products are themselves the source of the more alarming, less-sourced statistics circulating in this space. Procurement and budget decisions are best grounded in named, methodologically disclosed research — Verisk, ACFE/SAS, NICB, and similar bodies — rather than a vendor’s own unsourced claims about the scale of the problem.
– – Update SIU training for AI-specific tells. Traditional red flags — inconsistent metadata, repeat claimants, staged-looking photos — don’t reliably catch evidence that was specifically generated to pass casual visual review; investigator training should be refreshed to reflect that.

CMS Begins Auditing Carrier Section 111 Records

The Centers for Medicare & Medicaid Services has begun the machinery that, for the first time in the roughly 15-year history of mandatory Section 111 reporting, can turn a late Medicare Secondary Payer filing into a real dollar penalty. According to CMS’s own civil money penalty guidance pages, the agency began randomly auditing Section 111 records in January 2026 and is now working through its first round of noncompliance notices to insurers, self-insured employers, and workers’ compensation payers.

The penalties trace back to a final rule CMS published in the Federal Register on October 11, 2023, which took effect December 11, 2023, became applicable to new coverage events on October 11, 2024, and became enforceable, meaning penalties could actually attach, on October 11, 2025. The rule fills in details that Congress left to CMS’s discretion when it authorized penalties for Section 111 noncompliance back in 2013’s SMART Act.

Under the final rule, CMS narrowed what can trigger a penalty considerably from what it originally proposed. Early drafts would have allowed penalties for late reporting, for reporting that contradicted an entity’s earlier submissions during a recovery dispute, and for exceeding a data-quality error threshold in four of eight consecutive quarters. In the final version, CMS dropped the latter two triggers entirely; the sole basis for a civil money penalty now is late reporting, measured against a 365-day deadline running from a settlement date or the date an entity assumes ongoing responsibility for a claimant’s medical care.

The dollar amounts differ depending on the type of reporting entity. Group health plans face a flat penalty, currently $1,512 per day of noncompliance after inflation adjustment, with no discretion for CMS to reduce it, since the statute sets that rate directly. Non-group health plan entities, meaning liability insurers, no-fault carriers, and workers’ compensation payers, are subject to a tiered structure instead: $378 per day (2025, inflation-adjusted) for a record reported one to two years late, $756 per day for two to three years late, and $1,512 per day beyond three years, capped at $365,000 for any single record. CMS says it adopted the tiered approach, rather than mirroring the flat GHP rate, specifically in response to industry comments asking that penalty size track the severity of the delay.

To find violations, CMS is not scanning every submission. Instead, beginning in January 2026 and continuing every quarter, the agency randomly selects 250 records nationwide from newly accepted Section 111 filings, proportioned to reflect the actual mix of GHP and NGHP submissions that quarter. With roughly 20,800 active reporting entities registered, any individual company’s odds of being pulled into a given quarter’s sample are low, though CMS notes multiple records from the same entity can theoretically be selected.

An entity flagged in the audit receives an Informal Notice first, not an actual penalty, and has 30 days to submit mitigating evidence, such as documentation that a delay stemmed from a technical issue outside its control or from a beneficiary who refused to provide identifying information despite good-faith outreach. If CMS rejects that explanation or receives no response, the case proceeds to a formal Notice of Proposed Determination, and the entity can request a hearing before an administrative law judge within 60 days, followed by a further appeal to the Departmental Appeals Board’s Appellate Division. Notices go only to the entity’s Authorized Representative and Account Manager on file, according to CMS, and outdated contact information is not treated as an acceptable defense.

CMS reportedly told attendees at a January 15, 2026 webinar that its first informal notices for liability and no-fault claims were expected to go out in March 2026. Workers’ compensation reporting is on a delayed track: because CMS added new Medicare Set-Aside data fields to workers’ comp reporting requirements in April 2025, the earliest date CMS could issue a workers’-comp-related penalty notice is July 2026, according to that same account of CMS’s guidance. Those dates come from CMS’s public webinar remarks as relayed by outside counsel, not from the final rule’s text itself, and CMS’s own published materials describe the audit and notice cadence in general terms without committing to those specific calendar dates.

For employers and the insurance industry, the practical takeaway is that a rule which has existed on paper for more than two years is now generating actual audit activity, with real money attached for the first time. Self-insured employers and carriers that serve as Responsible Reporting Entities have reason to confirm their Section 111 profile contacts are current, and to review internal procedures with any third-party reporting agents, since CMS notices go to the RRE itself and reporting agents are not copied.

CMS’s own regulatory impact analysis, included in the final rule, flagged that the agency does not expect the penalty regime to be economically significant. Modeling the rule against 2022 reporting behavior, CMS estimated a worst-case aggregate of $128.8 million in penalties across the entire industry in a given year, below the $200 million threshold that would have required a fuller economic impact analysis, and CMS cautioned that the 2022 data likely overstates typical noncompliance since it predates entities’ efforts to come into compliance ahead of the rule.

This summary is for general informational purposes only; readers should consult the primary CMS guidance and Federal Register final rule linked above for complete, current data and methodology.

FBI’s Most Wanted Healthcare Fraudster List Fugitive Arrested

54 year old Khalid Ahmed Satary, a foreign national and a fugitive, was arrested on criminal charges related to his orchestration of a scheme to defraud Medicare over half a billion dollars for unnecessary genetic testing. The case dates back to 2019 when Satary was charged by indictment as part of one of the largest health care fraud schemes ever charged by the Department of Justice.

According to the indictment and court documents, from 2016 to 2019, Satary owned and operated several diagnostic testing laboratories throughout the United States that billed Medicare for expensive and medically unnecessary genetic tests. Satary allegedly conspired with dozens of patient recruiters, telemarketing call centers, and telemedicine companies to utilize deceptive marketing campaigns and illegal kickbacks and bribes to generate cancer genetic test samples that reimbursed between $10,000 to $20,000 per sample. Through his laboratories, Satary billed Medicare for over $547 million. He also allegedly paid millions of dollars in illegal kickbacks and bribes to doctors and patient recruiters. In connection with the indictment, the government seized 16 bank accounts and restrained real estate from Satary.

Following his indictment, Satary was released on bond, over the government’s objection, with a condition not to work in the health care field. While on bond, Satary allegedly conspired with Houston-based laboratories in Texas to continue submitting fraudulent genetic testing claims to Medicare. In December 2022, a federal arrest warrant was issued for Satary. He failed to appear for a court hearing and was believed to have subsequently fled the country.

On June 4, the FBI announced the creation of the Most Wanted Fraudsters List. The list included Herb Kimble, a fugitive in a $1.2 billion telemedicine and durable medical equipment scheme, who, on June 8—just four days later—was apprehended in the Philippines and was soon after charged as part of the 2026 National Health Care Fraud Takedown. On June 23, Satary was added to the Most Wanted Fraudsters List, and he was apprehended less than a month later, despite being on the run for over three years. On July 20, 2026, he was apprehended by regional partners in the Middle East and was found to be in possession of a fake Mexican passport under a fake name. He was subsequently transferred into U.S. custody.

Following his apprehension and return to the United States, Satary made his initial appearance in the Eastern District of Virginia. He is charged with conspiracy to commit health care fraud and wire fraud, health care fraud, conspiracy to defraud the United States and to pay and receive illegal health care kickbacks and bribes, and conspiracy to commit money laundering. If convicted, he faces a maximum penalty of 20 years in prison for the counts of conspiracy to commit wire fraud and conspiracy to commit money laundering, 10 years in prison for the counts of health care fraud and conspiracy to commit health care fraud, and five years in prison for the count of conspiracy to defraud the United States and to pay and receive kickbacks.

“The arrest of Khalid Ahmed Satary and return to the U.S. is the third Most Wanted Fraudster capture from this FBI and our partners in just 5 weeks – continuing the historic run of success for this new initiative,” said FBI Director Kash Patel. “Satary has been on the run since 2022, but we got him thanks to great work and coordination from the interagency and our overseas partners.

“This defendant allegedly orchestrated a massive fraud scheme that preyed on thousands of elderly patients, deceiving them into undergoing expensive, medically unnecessary tests and fraudulently billing the government for more than half a billion dollars,” said Acting Attorney General Blanche. “Thanks to the outstanding work of our partners at the FBI, this defendant was brought back from overseas to face justice in the United States. Our message to fraudsters is clear: If you steal from American taxpayers and exploit vulnerable patients, we will find and prosecute you, no matter where you are.”

On April 7, the Department of Justice announced the creation of the National Fraud Enforcement Division (“Fraud Division”). The Fraud Division is laser-focused on investigating and prosecuting those who commit fraud against the American people. The Department of Justice’s Health Care Fraud Strike Force Program, currently comprised of nine strike forces operating in federal districts across the country, has charged more than 6,200 defendants who collectively billed federal health care programs and private insurers more than $45 billion since 2007. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with the Office of the Inspector General for the Department of Health and Human Services, are taking steps to hold providers accountable for their involvement in health care fraud schemes.

Rand Reports on SB 1160 Effectiveness on UR and Medical Treatment

A new RAND Corporation study, Examining the Impact of Senate Bill 1160 on Utilization Review and Medical Treatment in California Workers’ Compensation, offers the first empirical look at whether a decade-old reform aimed at speeding up early medical care for injured workers actually worked. The report, published July 20, 2026 and sponsored by the California Department of Industrial Relations (DIR), finds that the 2016 law delivered a modest, measurable improvement in one key treatment area — but that utilization review (UR) was rarely the barrier the law was designed to remove in the first place.

Senate Bill 1160, enacted in 2016 and effective for injuries on or after January 1, 2018, exempted certain treatments provided in the first 30 days after a work injury from prospective UR — the process by which claims administrators approve, modify, or deny a treatment recommendation before care is delivered. Under the law, treatment for an accepted, compensable injury that is consistent with the Medical Treatment Utilization Schedule (MTUS) and delivered by a provider in the employer’s medical provider network is automatically authorized during that first month, without needing prospective sign-off. Claims administrators can still review those treatments retrospectively to check MTUS consistency, and a provider found to have a pattern of inconsistent care can be required to go back through prospective UR. The exemption reaches common early-stage treatments such as physical therapy and initial X-rays, but Labor Code section 4610(c), as amended by SB 1160, carved out several categories that remain subject to prospective UR even in the first 30 days, including surgery, pharmaceuticals, imaging other than X-rays, psychological treatment, home health care, and certain injections. All employers remain required to maintain a UR plan consistent with Labor Code section 4610 and its implementing regulations at 8 California Code of Regulations section 9792.6 et seq.

To evaluate the law’s effects, the RAND team — led by Stephanie Rennane and Michael Dworsky — combined four data sources: individual-level treatment-authorization records from two large claims administrators covering Northern and Southern California, statewide Independent Medical Review (IMR) data from DIR, DIR’s own UR audit reports, and medical billing data from the California Workers’ Compensation Information System (WCIS). The study period ran from January 2017 through January 2024, covering a full year before the law’s effective date and six years after. Researchers used interrupted time-series models to test for statistically significant shifts in UR approval rates, receipt of guideline-concordant care, and time to first treatment, before and after the January 1, 2018 implementation date.

The headline finding is that UR approval rates for treatment requested in the first 30 days after injury were already high before the law took effect — consistently above 90% at both claims administrators the researchers studied — and did not change in any statistically meaningful way afterward. That held true across nearly every treatment category the researchers examined, including physical therapy, imaging, surgery, and durable medical equipment. Approval rates for requests submitted later in a claim, by contrast, ran several percentage points lower throughout the study period, and treatment categories that SB 1160 left subject to full prospective review — imaging other than X-rays, injections, and psychiatric or psychological services — consistently showed the lowest approval rates of all, in the 70% to 90% range depending on the data source and category. In other words, the study suggests UR was rarely denying or slowing early, routine care even before SB 1160 removed the requirement to review it in advance. The researchers also found that many claims administrators already ran informal “prior authorization” programs that let common early treatments bypass the formal request-for-authorization process entirely, further reducing the friction SB 1160 was designed to eliminate.

Where the law did leave a measurable mark was physical therapy. Among injured workers with diagnoses for which physical therapy is clinically recommended, the odds of receiving it within 30 days of injury rose 13% after SB 1160 took effect, and the average time to a first physical therapy visit within that window dropped from 13.4 days before the law to 11.9 days after. Guideline-concordant use of braces and other immobilizers also rose modestly, with 8% higher odds of receipt within 30 days, though the timing of that care didn’t measurably speed up. Effects elsewhere were smaller and more mixed: receipt of guideline-concordant X-rays didn’t change significantly, consistent with X-rays already being commonly pre-authorized before the law; guideline-discordant acupuncture — treatment given for diagnoses where it isn’t recommended — actually rose 24% in relative terms after the law, though it remained rare in absolute terms, staying under 3% of cases throughout the study; and MRI use in the first 30 days declined slightly even though MRIs were explicitly excluded from SB 1160’s reduced-review provisions, a pattern the researchers attribute to unrelated trends rather than the law itself. Overall, the study concludes that SB 1160’s clearest, most defensible effect was on physical therapy access, and that the modest size of the effects generally reflects a system in which common early treatment was already flowing fairly freely before the reform.

The report closes with three recommendations for DIR and the Legislature. First, DIR should systematically document the informal prior-authorization programs claims administrators already run, since the report found meaningful, unexplained variation in which treatments different administrators pre-approve without any authorization request at all. Second, because most UR activity and most denials happen well after the first 30 days — and because treatments SB 1160 left fully subject to prospective review, particularly imaging and psychological services, have distinctly lower approval rates — the report suggests the Legislature examine whether reduced-review treatment could be extended further into a claim, or targeted more by treatment type and evidence strength than by a fixed 30-day window. Third, the researchers recommend DIR build out its planned systemwide UR database with standardized diagnosis and procedure codes and consistent claim identifiers, arguing that the absence of any comprehensive, uniform dataset on UR decisions was itself one of the central limitations of this study and remains an obstacle to evaluating future reforms.

Glenmark Pharmaceuticals Resolves Price Fixing Case for $29.6M

The California Attorney General has joined a coalition of 48 states and territories in a $29.6 million settlement with generic drug maker Glenmark Pharmaceuticals, resolving California’s and the other states’ claims that Glenmark took part in a sprawling, years-long conspiracy among generic drug manufacturers to fix prices, allocate customers, and rig bids across the industry. The California Attorney General announced the deal on July 16, 2026, calling the conduct at issue a straightforward harm to consumers and the marketplace. As part of the agreement, Glenmark also agreed to cooperate with the states’ ongoing litigation against dozens of remaining corporate and individual defendants and to adopt internal antitrust-compliance reforms.

The Glenmark settlement is the latest development in litigation that traces back nearly a decade. In December 2016, the Connecticut Attorney General and a group of other states filed the first of what would become three related civil complaints, alleging that six generic drug manufacturers, later expanded to 18 corporate defendants and two individual defendants, conspired over 15 generic drugs. A second complaint followed in 2019, naming Teva Pharmaceuticals and roughly 21 other major generic manufacturers, along with 16 individual senior executives, over a far larger set of 116 drugs. A third complaint, filed in 2020 and captioned Connecticut et al. v. Sandoz, Inc. et al., No. 3:20-cv-00802 (D. Conn.), targets 26 corporate defendants and 10 individual defendants over roughly 80 topical generic drugs used to treat skin conditions — a category the states say accounts for billions of dollars in annual U.S. sales. All three actions were originally filed in the District of Connecticut but were transferred for pretrial proceedings to the multidistrict litigation captioned In re: Generic Pharmaceuticals Pricing Antitrust Litigation, MDL No. 2724, in the U.S. District Court for the Eastern District of Pennsylvania, before the topical-drug case was remanded back to Connecticut, where it is now proceeding before U.S. District Judge Michael P. Shea.

The states describe their case as resting on an unusually deep evidentiary record: more than 20 million documents, a phone-records database covering millions of call detail records tied to more than 600 sales and pricing personnel across the generics industry, and testimony from multiple cooperating witnesses, including a two-volume notebook kept by one cooperator memorializing years of calls and internal meetings with competitors. According to the states’ filings, industry executives allegedly coordinated through industry dinners, golf outings, and frequent calls and texts, using phrases like “fair share” and “playing nice in the sandbox” to describe an informal, industry-wide understanding not to undercut each other on price.

The Connecticut case has continued to move forward even as individual defendants settle out. Court records show that in an October 2025 summary judgment ruling, Judge Shea addressed defense arguments that some of the states’ claims were barred by laches and the statute of limitations, narrowing the case in part while leaving the bulk of it intact. More significantly, in a December 2025 ruling, the court denied the defendants’ motion for summary judgment on whether an “overarching conspiracy” existed among the 26 corporate defendants that would make them jointly and severally liable, allowing the states’ central theory of the case to proceed toward trial. Along the way, individual states have seen mixed results on procedural motions — for example, Florida was permitted to withdraw certain claims in July 2025, while Tennessee’s state-law claims survived a motion to dismiss in April 2025.

Glenmark is not the first defendant to resolve its exposure short of trial. Two former Heritage Pharmaceuticals executives, Jeffery Glazer and Jason Malek, reached cooperation agreements early in the litigation. Heritage and Apotex settled in 2024 for a combined $49.1 million; Lannett and Bausch Health settled in February 2026 for a combined $17.85 million; and Glenmark’s $29.6 million settlement now brings total recoveries from settled defendants to roughly $96 million. Under the settlement, consumers and other purchasers who bought a generic drug manufactured by Glenmark, Lannett, Bausch, Apotex, or Heritage between May 2009 and December 2019 may be eligible for compensation, with claims administered through a dedicated hotline and the states’ joint case website, AGGenericDrugs.com.

As for what remains: the states’ press materials indicate that roughly 30 corporate defendants and 25 individual executives are still contesting the litigation across the three complaints, with seven additional pharmaceutical executives now cooperating as witnesses. The topical-drug case is expected to be the first of the three complaints to go to trial, with the states and reporting from other participating attorneys general offices projecting a trial date in Hartford sometime in late 2026 or early 2027, though no firm date had been set as of this settlement’s announcement. The other two complaints — covering the original 15-drug case and the larger 116-drug Teva-led case — remain pending behind the topical-drug case in the litigation queue.

Appellate Court Reverses WCAB and Approves Policy Cancellation

Employers Preferred Insurance Company issued a workers’ compensation policy to Purchase Green Artificial Grass covering May 5, 2020 to May 5, 2021 (the 2020 policy), followed by a renewal policy covering May 5, 2021 to May 5, 2022 (the 2021 policy). Like most workers’ comp policies, the premium quoted was only an estimate; the final premium would be calculated later based on the insured’s actual payroll, verified through an audit. The 2021 policy required Purchase Green to keep and turn over payroll records on request and to give the insurer access to perform a “payroll verification audit.” A separate endorsement warned that if the insured failed to provide access within 90 days after a policy’s expiration, it would owe a penalty premium of three times the estimated annual premium, plus the insurer’s audit-related costs if it still failed to respond after a third request over at least 90 days; the insurer would then notify the insured of that failure by certified mail, after which the insured would owe the premium and costs within 30 days, while still retaining up to three years to provide records and have its premium corrected.

After the 2020 policy expired, Employers Preferred sent Purchase Green repeated letters and emails in May, June, and August 2021 requesting payroll records, followed by a certified letter on August 5, 2021 (delivered August 10) formally notifying Purchase Green of its failure to provide access. That same day, Employers Preferred sent a notice cancelling the 2021 policy effective September 14, 2021, citing Purchase Green’s failure to cooperate with the final audit. Purchase Green never responded with payroll records during this period; its owner later testified he did not recall receiving any of the communications, including the cancellation notice. On February 3, 2022, a Purchase Green employee was injured and filed a workers’ compensation claim; Purchase Green paid its outstanding audit-related charges on February 18, 2022, but Employers Preferred denied the claim in May 2022 on the ground that the 2021 policy had already been canceled before the injury occurred.

The issue of insurance coverage proceeded to arbitration consistent with the Workers’ Compensation Appeals Board Rules. The arbitrator ruled the cancellation was ineffective, reasoning that neither the policy nor the Insurance Code precisely defined what conduct amounts to a “failure to permit” a payroll audit, and that cancelling a policy outright should require something more concrete than silence following three notices and the passage of 90 days. On reconsideration, the arbitrator adhered to that view, and on June 13, 2025, the Board adopted the arbitrator’s recommendation and denied Employers Preferred’s petition for reconsideration. Employers Preferred then petitioned the Court of Appeal for a writ of review challenging the Board’s decision, and the court issued the writ.

In the unpublished decision of Employers Preferred Insurance Company v. Workers’ Compensation Appeals Board No. C104263 (Cal. Ct. App., 3d Dist., July 2026) — the Court of Appeal annulled the Board’s June 13, 2025 order and remanded the matter to the Board for further proceedings.

Writing for a unanimous panel, Justice Robie reviewed the policy’s interpretation de novo, since insurance policies are ordinary contracts subject to the usual rules of contract interpretation, citing Bank of the West v. Superior Court (1992) 2 Cal.4th 1254 and Bay Cities Paving & Grading, Inc. v. Lawyers’ Mutual Insurance Co. (1993) 5 Cal.4th 854. Under Insurance Code section 676.8, a cancellation notice is effective for an insured’s “[f]ailure to permit the insurer to audit payroll as required by the terms of the policy,” but the statute lets the policy’s own terms define what that failure looks like. The panel agreed with the arbitrator that neither the policy’s main audit provision nor Insurance Code section 11760.1 (which separately allows a premium penalty for failing to provide audit access) used the exact phrase “failure to permit an audit,” and that several different deadlines appeared in the audit provision — 90 days before a penalty premium attaches, a further period before costs are added, 30 days after a certified letter before the increased premium is enforceable, and up to three years to still provide records and have the premium corrected.

But the court held that gap was not decisive. Citing the general rule that a contract should be interpreted reasonably and need not spell out every term with precision, citing Quantification Settlement Agreement Cases (2011) 201 Cal.App.4th 758 and Civil Code section 1643, the panel explained that the audit provision used the word “fail” throughout — failure to provide access within 90 days, failure after a third request, failure to show a compelling business reason — and expressly described the certified-letter notice as informing the insured of its “failure to provide access.” The only reasonable reading, the court held, was that the parties intended the certified-letter stage, not the later three-year window, to mark the point of “failure” that could justify cancelling a subsequent policy; reading the provision otherwise would let an insured delay a new policy’s cancellation for roughly 1,000 additional days, an outcome the panel found unreasonable given the policy’s one-year term. Because Purchase Green never responded to any of the insurer’s requests and never offered a compelling business reason for its silence, the court held Employers Preferred’s cancellation, sent 35 days after the certified letter was delivered, satisfied both the 2021 policy and section 676.8. The panel added that not every contractual phrase must be independently defined to avoid ambiguity, citing Bay Cities Paving, and that courts should not manufacture ambiguity where a strained reading is the only way to find it.

The panel went on to reject Purchase Green’s three alternative arguments for invalidating the cancellation. It rejected the argument that the Insurance Code required Employers Preferred to conduct “personal outreach” rather than automated notices, because Purchase Green never showed the policy’s own language required anything beyond what the insurer did. It rejected the argument that Purchase Green’s failure to respond had to be shown to be intentional or willful, holding that the policy’s obligation was to affirmatively provide records once requested, regardless of motive. And it rejected Purchase Green’s equitable estoppel argument — based on a February 8, 2022 letter that incorrectly listed the 2021 policy’s coverage period as running through May 2022 — because equitable estoppel requires detrimental reliance, citing Honeywell v. Workers’ Compensation Appeals Board (2005) 35 Cal.4th 24, and that letter was sent five days after the employee’s injury, so Purchase Green could not have relied on it at the time coverage mattered. On that basis, the panel annulled the Board’s order and remanded for further proceedings, with costs to Employers Preferred.

California Overhauls Subsequent Injuries Benefits Trust Fund

Governor Gavin Newsom has signed sweeping changes to California’s Subsequent Injuries Benefits Trust Fund (SIBTF), capping an 18-month fight over a workers’ compensation program that grew, by the state’s own account, until it rivaled the size of the entire standard workers’ compensation system.

SIBTF dates to 1945, when California created it to encourage employers to hire disabled World War II veterans: if a worker with a pre-existing disability suffered a new, unrelated workplace injury and the combination left them severely disabled, the fund — not the employer — would cover the added cost. For decades it was a minor corner of the system. That changed over the past ten years. According to the Legislative Analyst’s Office, in a July 2025 report, the fund “now rivals the size of the standard workers’ compensation system but with looser standards, broader eligibility, and more generous benefits.” Employer assessments that funded SIBTF rose from roughly $14 million in 2015 to nearly $850 million by 2025, and a 2024 RAND Corporation study commissioned by the Department of Industrial Relations put the fund’s total potential future liability at $7.9 billion, with a plausible range of $6.4 billion to $10.5 billion. The RAND and LAO reports both pointed to a 2020 Workers’ Compensation Appeals Board en banc decision, Todd v. Subsequent Injuries Benefits Trust Fund, as a major driver, finding that it had significantly loosened the disability-combination rules that determine who qualifies.

That backdrop is what prompted the law. In October 2025, Newsom vetoed an earlier, narrower reform bill, AB 1329 by Assemblymember Liz Ortega, D-San Leandro, saying it did not go far enough. In his veto message, Newsom wrote that the program had “expanded beyond its original purpose” and directed the Department of Industrial Relations and the Division of Workers’ Compensation to build a comprehensive reform plan for the 2026-27 budget cycle. That plan arrived as proposed budget trailer bill language in early 2026 and, after months of committee hearings, became Senate Bill 171, the “Labor” trailer bill attached to this year’s state budget.

The bill was contentious throughout. Business and public-employer groups, including a coalition of counties, cities, and industry associations, backed the changes; in an April 2026 letter, that coalition urged lawmakers to “take swift action to pass this bill through the budget process.” Labor and injured-worker advocates pushed back hard on both the substance and the process. The Coalition of California Injured Workers, a coalition of labor organizations, public safety associations, and injured-worker advocacy groups, publicly urged the Governor and Legislature to strip the SIBTF provisions out of the budget trailer bill entirely and instead send them through the regular legislative process, where they would get full committee vetting and public input. The group cited a poll it commissioned finding that 64% of likely California voters opposed the proposed SIBTF changes once informed of their impact, and that 79% believed reforms of this scope should not be fast-tracked through a budget trailer bill. Assemblymember Ortega’s California Applicants’ Attorneys Association allies raised a related but somewhat more measured concern: at a June 17, 2026 hearing before the Senate Labor, Public Employment and Retirement Committee, former Assemblymember Alberto Torrico, testifying for the CAAA, acknowledged “there is a serious problem with the SIBTF” but argued its roots include understaffing at the agency as much as the Todd decision, and Ortega continued pushing a competing, less sweeping bill, AB 1576, through the same period. Separately, a self-described investigative outlet, The Jacobi Journal, published an analysis in January 2026 disputing the RAND report’s headline $7.9 billion liability figure, arguing that adjusting the study’s discount-rate and payout assumptions would put the real number closer to $1.25 billion — a claim RAND and DIR have not publicly conceded, but one opponents of the trailer bill cited as reason to doubt the urgency behind it.

Despite that opposition, SB 171 passed the Legislature along largely party-line-adjacent budget votes in the final days of June 2026 and was enrolled to the Governor’s desk on June 30. Newsom signed it on Monday, July 13, 2026.

As signed, SB 171 changes SIBTF eligibility and claims-handling in several concrete ways. It adds a statutory definition of “labor disabling” to the Labor Code for the first time, limiting qualifying pre-existing disabilities to impairments that caused a loss of earnings, interfered with the worker’s ability to do their job, or otherwise had a demonstrable impact on their capacity to work — replacing a looser, case-law-based standard. It requires that the existence of a pre-existing disability be proven by substantial evidence drawn from medical records, testimony, or other evidence that predates the subsequent work injury, rather than being established after the fact. It also excludes the future-earning-capacity adjustment and the 1.4 permanent-disability multiplier from the calculation used to determine whether a worker clears the eligibility threshold, and it codifies clearer standards for calculating benefit amounts once eligibility is established. On process, the bill shifts responsibility for paying SIBTF awards from the State Compensation Insurance Fund to the Director of Industrial Relations, acting as trustee of the fund, and it clarifies that workers have five years from a subsequent injury, or six months from the resolution of the permanent disability portion of that injury claim, whichever is later, to file a SIBTF claim. Separately, the bill permanently removes the sunset date on a related provision, Labor Code section 5909, which gives the Workers’ Compensation Appeals Board 60 days from receiving a case file to act on a petition for reconsideration.

The new SIBTF eligibility rules took effect immediately upon signing, since SB 171 is a budget-related bill declared to take effect immediately, but they do not apply retroactively across the board. The law exempts claims that had already reached a specified procedural stage as of June 1, 2026, as well as any claim filed on or before July 1, 2020, from the new standards, leaving those claims to be decided under the prior rules. The new eligibility and calculation provisions are also not permanent as written: the bill makes them inoperative on July 1, 2031, and repeals them outright as of January 1, 2032, meaning the Legislature will need to revisit the program again before the decade is out.

QME to Assign Percent Causation of Good Faith Personnel Action Event

Maria Lopez Rodriguez worked as a medical receptionist for Kern County Hospital Authority, permissibly self-insured and administered by Adminsure, Inc. She claimed a psychiatric injury arising out of and in the course of her employment on November 15, 2017, attributing her symptoms to ongoing conduct by her supervisor, Marie Ruffin.

A qualified medical evaluator (QME), Dr. Greg Hirokawa, took a history in which applicant described her supervisor searching for reasons to reprimand her, denying her a requested transfer, standing over her while giving instructions, and asking coworkers how often applicant used the restroom, among other incidents she said had gone on for roughly 18 to 24 months. Dr. Hirokawa diagnosed an anxiety disorder and opined that work stress was the predominant (greater than 50%) cause of applicant’s psychological symptoms, and that personnel actions by her supervisor accounted for roughly 80% of that work stress — but he left it to the trier of fact to determine whether the supervisor’s actions were lawful, nondiscriminatory, and in good faith

The workers’ compensation administrative law judge (WCJ) found that applicant sustained a psychiatric injury arising out of and in the course of employment, and that her claim was not barred by the good faith personnel action defense under Labor Code section 3208.3(h). In the accompanying Opinion on Decision, the WCJ identified four incidents — the shoulder grab, the shortened lunch, the church-toys directive, and the yelling — and stated that, while defense witnesses had described other incidents that were good faith personnel actions, the incidents applicant testified to were not, and so did not bar her claim. The WCJ adopted Dr. Hirokawa’s causation opinion in full. Kern County Hospital Authority filed a timely petition for reconsideration, arguing the WCJ misapplied the good faith personnel action defense and that the decision was not supported by substantial evidence.

In the appended Opinion on Decision (Opinion), the WCJ addressed the good faith personnel action defense by simply stating “While Defendant witnesses discussed other incidents that were good-faith personnel actions, those discussed by Applicant were are (sic) not good-faith- personnel actions. This defense does not bar the claim of Applicant based on the incidents Applicant testified to.”

The WCJ adopted Dr. Hirokawa’s opinion on causation, stating: AOE/COE – Parts of the Body Injured “Dr. Hirokawa stated that the predominant cause of Applicant’s symptoms were from work stress. Approximately 80 percent of that stress was due to personnel actions by Applicant’s supervisor. Dr. Hirokawa left it to the trier of fact to determine if the supervisor’s actions were legal, non-discriminatory, and non-retaliatory. These actions are being found not to be good-faith-personnel actions. Based on Dr. Hirokawa’s report, Applicant has suffered industrial injury to the psyche.”

In the panel decision of Rodriguez v. Kern County Hospital Authority, ADJ11141161 (Cal. Workers’ Comp. Appeals Bd., July 2026) — the WCAB granted reconsideration and rescinded the WCJ’s Findings and Orders in their entirety, returning the matter to the trial level for further proceedings.

The panel applied the four-step framework the Board adopted in its en banc decision in Rolda v. Pitney Bowes, Inc. (2001) 66 Cal.Comp.Cases 241, for evaluating a psychiatric injury claim once an employer raises the good faith personnel action defense under Labor Code section 3208.3. Under Rolda, the WCJ must determine, in sequence: whether the claimed injury involves actual events of employment; whether those events were the predominant (over 50%) cause of the injury; whether any of those events were personnel actions that were lawful, nondiscriminatory, and in good faith; and, if so, whether those good faith personnel actions were a “substantial cause” — 35% to 40% of all causation — of the injury. The first two steps are applicant’s burden; the latter two are the employer’s. The panel found the first two steps effectively conceded, since defendant did not dispute that applicant’s described incidents were actual events of employment or that Dr. Hirokawa had found predominant industrial causation.

The problem, the panel explained, arose at the third step. The point of that step is to sort the actual events of employment into those that were good faith personnel actions and those that were not, but the WCJ’s Opinion on Decision never made clear which of applicant’s described incidents — which the panel noted seemed to include more than the four specifically discussed — the WCJ was treating as the operative events, or why. Citing the Board’s en banc decision in Hamilton v. Lockheed Corporation (2001) 66 Cal.Comp.Cases 473, and Labor Code section 5313, the panel explained that a WCJ’s opinion must refer with specificity to the evidence relied upon and clearly set out the reasons for the decision on each issue, so that the parties and the Board can meaningfully evaluate it on reconsideration; a decision must be based on admitted evidence in the record and supported by substantial evidence, citing Hegglin v. Workmen’s Comp. Appeals Bd. (1971) 4 Cal.3d 162, among other cases.

That gap mattered because of what the fourth Rolda step requires. Unlike the “predominant cause” inquiry, which looks only at causation as to all events combined, the “substantial cause” inquiry requires the evaluating physician to parse out the individual events found to be good faith personnel actions and assign a percentage of causation to each. Dr. Hirokawa’s report discussed several potential contributing factors but did not analyze each one individually or assign percentages, and the panel reasoned that any such breakdown would necessarily be unreliable if the physician did not know, because the WCJ had never clearly said, which events actually qualified as good faith personnel actions. The panel also noted, in a footnote, that whether a given event is a “personnel action” taken in “good faith” is a factual and legal determination for the WCJ to make, not the QME — so Dr. Hirokawa’s own use of that label in his report, offered before the WCJ made any such finding, could not substitute for the missing determination, citing County of Sacramento v. Workers’ Comp. Appeals Bd. (Brooks) (2013) 215 Cal.App.4th 785.

Concluding that the record could not currently support a finding either way on whether the good faith personnel action defense barred the claim, the panel held the correct course was to develop the record further rather than resolve the issue on an incomplete record, citing the Board’s en banc decision in McDuffie v. Los Angeles County Metropolitan Transit Authority (2002) 67 Cal.Comp.Cases 138 and a recent panel decision reaching the same conclusion on similar facts, Silva v. Department of Transportation Headquarters Operations (2025, ADJ13014565). The Board directed that, on remand, the parties return to Dr. Hirokawa for supplemental reporting under Labor Code section 5701, or that the WCJ appoint a regular physician if his further reporting does not constitute substantial evidence, while noting the parties always retain the option of proceeding by agreed medical evaluator instead. On that basis, the panel rescinded the WCJ’s Findings and Orders and returned the matter to the trial level.

Grand Jury Says Ventura County Has Best in Class Claims Program

The Ventura County Civil Grand Jury has released a new report, Setting the Record Straight on Presumptive Workers’ Compensation Claims, examining how Ventura County processes “presumptive” workers’ compensation claims for deputy sheriffs and firefighters — and largely vindicating the county’s recent overhaul of that process while flagging structural problems baked into state law itself.

Presumptive claims exist for “safety workers,” a category the Legislature created in 1937 for law enforcement officers, firefighters, and similar high-risk public employees (Cal. Gov. Code, §§ 20390–20416). For a defined list of conditions — including heart trouble, hernia, pneumonia, cancer, tuberculosis, and blood-borne infections — the law presumes the injury or illness arose out of employment, shifting the burden onto the employer to rebut that presumption rather than requiring the worker to prove causation (Cal. Lab. Code, §§ 3212–3214). The Grand Jury notes this framework traces to a genuine, decades-old scientific dispute over whether stress and physical exertion cause conditions like heart disease and cancer, a dispute it says has only been resolved by research in recent years; the report cites the California Supreme Court’s 1978 decision in City and County of San Francisco v. Workers’ Compensation Appeals Board, which addressed the “persisting cleavage in medical theory” that made these claims so contentious.

The Grand Jury’s investigation was prompted by longstanding complaints from Ventura County Sheriff’s Office (VCSO) deputies that presumptive claims were being denied without justification, that treatment was delayed, and that filing a claim effectively required hiring a lawyer. The jury found those perceptions were rooted in real problems, but concluded that Ventura County Risk Management has substantially fixed them since 2023 through a series of administrative changes: eliminating the requirement that injured workers choose a doctor from a restricted network; a “FastTrack” arrangement with Ventura Orthopedics that sends deputies straight to evaluation and treatment for duty-belt-related back injuries with no utilization review; automatic pre-approval of diagnostic tests ordered by a treating physician; guaranteed access to three major Southern California cancer centers (City of Hope, USC Norris, and UCLA Jonsson) for approved cancer claims; the option to substitute a chosen specialist’s second opinion for a formal Qualified Medical Evaluator (QME) in some cases; and the addition of three claims examiners dedicated specifically to VCSO and Ventura County Fire Department (VCFD) claims.

The county’s own data shows the payoff: the share of workers’ comp claimants who retained a lawyer fell from 65% before 2023 to 22% between 2023 and the end of 2025, and insurance rates for the two safety departments have declined for three consecutive years.

Even so, the report identifies a structural flaw in state law that county-level administrative fixes cannot solve. When a QME’s opinion is needed to resolve a disputed claim, the jury found, the examiner routinely cannot meet the 75-day statutory deadline, leaving both the county and the worker in limbo. The report also flags a related problem: California’s QME system struggles to recruit specialists in fields like oncology and cardiology, and the jury cites an example of a Ventura County deputy with a serious back injury whose QME opinion came from a podiatrist, plus a case in which a claim was kicked back over a data-entry date error despite two accompanying documents showing the correct date.

The jury’s numbers give a sense of scale: between January 2023 and October 2025, only 39 of VCSO’s 578 workers’ compensation claims were presumptive claims. Of those 39, only 10 were accepted quickly (an average of 13 days), 14 were accepted within the 75-day window, and 15 were denied within that window; of the denials, 8 were later reversed once new supporting evidence came in, and 7 remain denied and undisputed — five of those seven were COVID-19 claims, which are no longer covered by the presumption.

The report makes ten findings and ten recommendations, aimed mainly at the VCSO, County Risk Management, and the Board of Supervisors, with response deadlines running through the end of 2026. Among them: formalize regular communication between VCSO and Risk Management (R-01, R-02); train HR staff and supervisors on presumptive-claims rules (R-03); proactively educate deputies on their claims-process rights and responsibilities within three years of hire (R-04); create a dedicated advocate role within VCSO to guide injured deputies through the claims and treatment process, modeled on a similar role VCFD already uses (R-05); better publicize the state Division of Workers’ Compensation’s Information and Assistance Unit, a free advocacy resource for claimants that the jury found is underused (R-06); add preventive health screening and wellness programs for deputies similar to VCFD’s (R-07); build out more substantive “light duty” assignments for recovering deputies (R-08); have the County Auditor-Controller finally audit the cost of covering deputies’ leaves of absence with overtime, which the Sheriff’s Office estimates runs into the millions annually but has never been formally measured (R-09); and, notably, petition state lawmakers to reconcile the mismatched 75-day and 90-plus-day statutory deadlines (R-10).

The Grand Jury closes by commending both Ventura County Risk Management and VCFD by name for building what it calls a “best-in-class” claims program, while cautioning that the county’s improvements can’t by themselves fix a claims timeline that state law itself sets up to fail. Responses are required from the Board of Supervisors within 90 days and from the Sheriff and County Auditor-Controller within 60 days; responses are invited but not required from the County Executive Officer and the VCFD Chief.